These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29073181)

  • 1. Modulation of T-type Ca2+ channels by Lavender and Rosemary extracts.
    El Alaoui C; Chemin J; Fechtali T; Lory P
    PLoS One; 2017; 12(10):e0186864. PubMed ID: 29073181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological studies of Cav3.1 T-type calcium channels using automated patch-clamp techniques.
    Choi KH; Song C; Cheong CS; Rhim H
    Gen Physiol Biophys; 2011 Mar; 30(1):100-5. PubMed ID: 21460418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heantos-4, a natural plant extract used in the treatment of drug addiction, modulates T-type calcium channels and thalamocortical burst-firing.
    Cain SM; Ahn S; Garcia E; Zhang Y; Waheed Z; Tyson JR; Yang Y; Van Sung T; Phillips AG; Snutch TP
    Mol Brain; 2016 Dec; 9(1):94. PubMed ID: 27919294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of the Cav3.2 T-type calcium channel directly regulates its gating properties.
    Blesneac I; Chemin J; Bidaud I; Huc-Brandt S; Vandermoere F; Lory P
    Proc Natl Acad Sci U S A; 2015 Nov; 112(44):13705-10. PubMed ID: 26483470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subunit-specific modulation of T-type calcium channels by zinc.
    Traboulsie A; Chemin J; Chevalier M; Quignard JF; Nargeot J; Lory P
    J Physiol; 2007 Jan; 578(Pt 1):159-71. PubMed ID: 17082234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphenol A differently inhibits CaV3.1, Ca V3.2 and Ca V3.3 calcium channels.
    Michaela P; Mária K; Silvia H; L'ubica L
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Feb; 387(2):153-63. PubMed ID: 24170242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrogen sulfide inhibits Cav3.2 T-type Ca2+ channels.
    Elies J; Scragg JL; Huang S; Dallas ML; Huang D; MacDougall D; Boyle JP; Gamper N; Peers C
    FASEB J; 2014 Dec; 28(12):5376-87. PubMed ID: 25183670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cav3.2/alpha1H T-type Ca2+ current is a molecular determinant of excitatory effects of GABA in adult sensory neurons.
    Aptel H; Hilaire C; Pieraut S; Boukhaddaoui H; Mallié S; Valmier J; Scamps F
    Mol Cell Neurosci; 2007 Oct; 36(2):293-303. PubMed ID: 17716912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of neuronal cav3.1 channels by cyclin-dependent kinase 5 (Cdk5).
    Calderón-Rivera A; Sandoval A; González-Ramírez R; González-Billault C; Felix R
    PLoS One; 2015; 10(3):e0119134. PubMed ID: 25760945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase A regulation of T-type Ca2+ channels in rat cerebral arterial smooth muscle.
    Harraz OF; Welsh DG
    J Cell Sci; 2013 Jul; 126(Pt 13):2944-54. PubMed ID: 23613468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The involvement of Cav3.2/alpha1H T-type calcium channels in excitability of mouse embryonic primary vestibular neurones.
    Autret L; Mechaly I; Scamps F; Valmier J; Lory P; Desmadryl G
    J Physiol; 2005 Aug; 567(Pt 1):67-78. PubMed ID: 15961427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of recombinant Ca(v)3.1 (alpha(1G)) T-type calcium channels by the antipsychotic drug clozapine.
    Choi KH; Rhim H
    Eur J Pharmacol; 2010 Jan; 626(2-3):123-30. PubMed ID: 19782679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short- and long-term amiodarone treatments regulate Cav3.2 low-voltage-activated T-type Ca2+ channel through distinct mechanisms.
    Yamashita N; Kaku T; Uchino T; Isomoto S; Yoshimatsu H; Ono K
    Mol Pharmacol; 2006 May; 69(5):1684-91. PubMed ID: 16443692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of T-type Ca2+ Channels by Hydrogen Sulfide.
    Elies J; Scragg JL; Dallas ML; Huang D; Huang S; Boyle JP; Gamper N; Peers C
    Adv Exp Med Biol; 2015; 860():353-60. PubMed ID: 26303500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of novel N3-substituted dihydropyrimidine derivatives as T-type calcium channel blockers and their efficacy as analgesics in mouse models of inflammatory pain.
    Teleb M; Zhang FX; Huang J; Gadotti VM; Farghaly AM; AboulWafa OM; Zamponi GW; Fahmy H
    Bioorg Med Chem; 2017 Mar; 25(6):1926-1938. PubMed ID: 28233679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-type calcium channel antagonist, TTA-A2 exhibits anti-cancer properties in 3D spheroids of A549, a lung adenocarcinoma cell line.
    Kumari N; Bhargava A; Rath SN
    Life Sci; 2020 Nov; 260():118291. PubMed ID: 32810510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of Residues of Diazinon and Chlorpyrifos in Lavender and Rosemary Leaves by Gas Chromatography.
    Rezk MR; Abd El-Aleem AEB; Khalile SM; El-Naggar OK
    J AOAC Int; 2018 Mar; 101(2):587-592. PubMed ID: 28821307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of T-type Ca2+ channels in primary sensory neurons in spinal nerve injury.
    Yue J; Liu L; Liu Z; Shu B; Zhang Y
    Spine (Phila Pa 1976); 2013 Mar; 38(6):463-70. PubMed ID: 22972512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of neuronal T-type calcium channels.
    Lambert RC; Bessaih T; Leresche N
    CNS Neurol Disord Drug Targets; 2006 Dec; 5(6):611-27. PubMed ID: 17168746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
    Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.